T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

K. Mihara; J. Bhattacharyya; A. Kitanaka; K. Yanagihara; T. Kubo; Y. Takei; H. Asaoku; Y. Takihara; A. Kimura

doi:10.1038/leu.2011.205

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

K. Mihara
, J. Bhattacharyya
, A. Kitanaka
, K. Yanagihara
, T. Kubo
, Y. Takei
, H. Asaoku
, Y. Takihara
, A. Kimura

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	365-367
Number of pages	3
Journal	Leukemia
Volume	26
Issue number	2
DOIs	https://doi.org/10.1038/leu.2011.205
Publication status	Published - 02-2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2011.205

Cite this

@article{2dda5139d82a400385bbebbea4dc01bb,

title = "T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells",

author = "K. Mihara and J. Bhattacharyya and A. Kitanaka and K. Yanagihara and T. Kubo and Y. Takei and H. Asaoku and Y. Takihara and A. Kimura",

note = "Funding Information: leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. Br J Haematol 2009; 146: 54–63.",

year = "2012",

month = feb,

doi = "10.1038/leu.2011.205",

language = "English",

volume = "26",

pages = "365--367",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

AU - Mihara, K.

AU - Bhattacharyya, J.

AU - Kitanaka, A.

AU - Yanagihara, K.

AU - Kubo, T.

AU - Takei, Y.

AU - Asaoku, H.

AU - Takihara, Y.

AU - Kimura, A.

N1 - Funding Information: leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. Br J Haematol 2009; 146: 54–63.

PY - 2012/2

Y1 - 2012/2

UR - https://www.scopus.com/pages/publications/84856760798

UR - https://www.scopus.com/pages/publications/84856760798#tab=citedBy

U2 - 10.1038/leu.2011.205

DO - 10.1038/leu.2011.205

M3 - Letter

C2 - 21836610

AN - SCOPUS:84856760798

SN - 0887-6924

VL - 26

SP - 365

EP - 367

JO - Leukemia

JF - Leukemia

IS - 2

ER -

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this